scispace - formally typeset
L

Lise Tarnow

Researcher at Steno Diabetes Center

Publications -  270
Citations -  14538

Lise Tarnow is an academic researcher from Steno Diabetes Center. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 68, co-authored 267 publications receiving 13419 citations. Previous affiliations of Lise Tarnow include Aarhus University & Health Science University.

Papers
More filters
Journal ArticleDOI

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

TL;DR: The establishment of a reproducible, high resolution method for peptidome analysis of naturally occurring human urinary peptides and proteins, ranging from 800 to 17,000 Da, using samples from 3,600 individuals analyzed by capillary electrophoresis coupled to MS is reported.
Journal ArticleDOI

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study.

TL;DR: Around one third of patients newly diagnosed with type 1 diabetes develop persistent microalbuminaria and persistent macroalbuminuria within the first 20 years of diabetes.
Journal ArticleDOI

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

TL;DR: Improved glycemic control, lower blood pressure, and reduced prevalence of smoking rates were associated with the improved prognosis in patients followed for >/=20 years.
Journal ArticleDOI

Progression of diabetic nephropathy

TL;DR: The prognosis of diabetic nephropathy has improved during the past decades, predominantly because of effective antihypertensive treatment, and several modifiable variables have been identified as progression promoters.
Journal ArticleDOI

Progression of nephropathy in type 2 diabetic patients.

TL;DR: The authors' long-term prospective study of type 2 diabetic patients with nephropathy has revealed several modifiable risk factors of enhanced progression in kidney disease and increased mortality.